The African continent which is home for more than 1.3 billion people imports 80 percent of its biopharmaceutical and medical consumables. However, most African countries do not have a strong regulatory system and often times lack resources to perform quality control on imported biopharmaceutical and medical products. These problems have led to a huge spread of counterfeit drugs throughout the continent. According to the World Health Organization more than 42 percent of counterfeit drugs sold globally between 2013 and 2017 were in Africa, accounting for nearly $80 billion.
Since 2013, Afeli Pharmaceuticals has been working diligently to address the crucial needs for high-quality healthcare products throughout the African continent. Our mission is to offer solutions that address the unmet needs of high-quality biopharmaceutical products in Africa from strategy to implementation.
Dr. Afeli was born in Cote d’Ivoire (Ivory Coast) and raised in a family of six children in the city of Abidjan before immigrating to the United States to attend college and complete his higher education degrees. Dr. Afeli holds a bachelor’s degree in physical sciences from Kansas State University, a PhD degree in pharmaceutical sciences from the University of South Carolina College of Pharmacy, and a master’s degree in Healthcare Administration from the University of Alabama at Birmingham.
Dr. Afeli is currently a tenured Associate Professor of Pharmacology and Director of Pharmacy Innovation and Entrepreneurship at Presbyterian College School of Pharmacy. He is the author of more than two dozen peer-reviewed research articles in the field of urology, bladder cancer, pharmacy education and entrepreneurship. Dr. Afeli has more than 12 years of experience in pharmacological research and his scientific publications have provided significant insight in the pathophysiology of overactive bladder, a disease that affect ~33 million people in the U.S. alone.
Serge Afeli, PhD, MSHA
Legal and Strategy Advisor
Partner at Arrington-Owoo Law Firm
Financial Strategy Advisor
Principal at Parallel Financials LLC
Pharmaceutical Strategy Advisor
Global Health Economics and Outcomes Research at Pfizer
Business Strategy Advisor
CEO of Oliver Trading Inc.,